The Blood Pressure "Uncertainty Range" – a pragmatic approach to overcome current diagnostic uncertainties (II)

Current Controlled Trials in Cardiovascular Medicine - 2005
Cornel Pater1
1Chippenham, UK

Tóm tắt

Abstract A tremendous amount of scientific evidence regarding the physiology and physiopathology of high blood pressure combined with a sophisticated therapeutic arsenal is at the disposal of the medical community to counteract the overall public health burden of hypertension. Ample evidence has also been gathered from a multitude of large-scale randomized trials indicating the beneficial effects of current treatment strategies in terms of reduced hypertension-related morbidity and mortality. In spite of these impressive advances and, deeply disappointingly from a public health perspective, the real picture of hypertension management is overshadowed by widespread diagnostic inaccuracies (underdiagnosis, overdiagnosis) as well as by treatment failures generated by undertreatment, overtreatment, and misuse of medications. The scientific, medical and patient communities as well as decision-makers worldwide are striving for greatest possible health gains from available resources. A seemingly well-crystallised reasoning is that comprehensive strategic approaches must not only target hypertension as a pathological entity, but rather, take into account the wider environment in which hypertension is a major risk factor for cardiovascular disease carrying a great deal of our inheritance, and its interplay in the constellation of other, well-known, modifiable risk factors, i.e., attention is to be switched from one's "blood pressure level" to one's absolute cardiovascular risk and its determinants. Likewise, a risk/benefit assessment in each individual case is required in order to achieve best possible results. Nevertheless, it is of paramount importance to insure generalizability of ABPM use in clinical practice with the aim of improving the accuracy of a first diagnosis for both individual treatment and clinical research purposes. Widespread adoption of the method requires quick adjustment of current guidelines, development of appropriate technology infrastructure and training of staff (i.e., education, decision support, and information systems for practitioners and patients). Progress can be achieved in a few years, or in the next 25 years.

Từ khóa


Tài liệu tham khảo

2003 European Society of Hypertension – European Society of Cardiology guidelines for the management of arterial hypertension. Journal of Hypertension. 2003, 21: 1011-1053. 10.1097/00004872-200306000-00001.

World Health Organization, International Society of Hypertension Writing Group: 2003 World Health Organization (WHO/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens. 2003, 21: 1983-1992.

Anderson KV, Odell PM, Wilson PWF, Kannel WB: Cardiovascular disease risk profiles. Am Heart J. 1991, 121: 293-298. 10.1016/0002-8703(91)90861-B.

Jackson RJ, Lawes CMM, Bennett DA, Milne RJ, Rodgers A: Treating Individuals 5: Treatment with drugs to lower blood pressure and blood cholesterol based on an individual's absolute cardiovascular risk. Lancet. 2005, 365: 434-441.

Volpe M, Alderman MH, Furberg CD, Jackson R, Kostis JB, Laragh JH, Psaty BM, Ruilope LM: Beyond hypertension. Toward guidelines for cardiovascular risk reduction. Am J Hypertens. 2004, 17 (11): 1068-1074. 10.1016/j.amjhyper.2004.06.017.

Mancia G, Grassi G: Systolic and diastolic blood pressure control in antihypertensive drug trials. J Hypertens. 2002, 20: 1461-1464. 10.1097/00004872-200208000-00001.

Prospective Studies Collaboration: Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002, 360: 1903-1913. 10.1016/S0140-6736(02)11911-8.

Law MR, Wald NJ: Risk factor thresholds: their existence under scrutiny. BMJ. 2002, 324: 1570-1576. 10.1136/bmj.324.7353.1570.

Rodgers A: Quantifying selected major risks to health. The world health report 2002: reducing risks, promoting healthy life. Edited by: Murray CJL, Lopez Ad. 2002, Geneva: WHO, 47-92.

Neaton JD, Wenthworth D, for the Multiple Risk Factor Intervention Trial Research Group: Serum Cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Overall findings and differences by age for 316,099 white men. Arch Intern Med. 1992, 152: 56-54. 10.1001/archinte.152.1.56.

Asia Pacific Cohort Studies Collaboration: Cholesterol, coronary heart disease and stroke in the Asia Pacific Region. Int J Epidemiol. 2003, 32: 563-572. 10.1093/ije/dyg106.

Asia Pacific Cohort Studies Collaboration: Blood pressure and Cardiovascular disease in the Asia Pacific Region. J Hypertens. 2003, 21: 707-716.

Eastern Stroke and Coronary Heart Disease collaborative Research Group: Blood pressure, cholesterol, and stroke in Eastern Asia. Lancet. 1998, 352: 1801-1807. 10.1016/S0140-6736(98)03454-0.

William BW: Ambulatory blood-pressure monitoring in clinical practice. New Engl J Med. 2003, 348 (24): 2377-2378. 10.1056/NEJMp030057.

Little P, Barnet J, Barnsley L, Marjoram J, Fitzgerald-Baron A, Mant D: Comparison of agreement between different measures of blood pressure in primary care and daytime ambulatory blood pressure. BMJ. 2002, 325: 254-259. 10.1136/bmj.325.7358.254.

Bellomo G, Narducci PL, Rondoni F, Pastorelli G, Stagnoni G: Prognostic value of 24-hour blood pressure in pregnancy. JAMA. 1999, 282: 1447-1452. 10.1001/jama.282.15.1447.

Staessen JA, Fagard R, Thjis L: Randomized double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet. 1997, 350: 757-764. 10.1016/S0140-6736(97)05381-6.

O'Brian E: Ambulatory blood pressure monitoring in the management of hypertension. Heart. 2003, 89: 571-576. 10.1136/heart.89.5.571.

MacDonald MB, Laing GP, Wilson MP, Wilson TW: Prevalence and predictors of white-coat response in patients with treated hypertension. Can Med Assoc J. 1999, 161: 265-269.

Pickering T, Davidson K, Gerin W: Masked hypertension. Hypertension. 2002, 40: 795-796. 10.1161/01.HYP.0000038733.08436.98.

Guillaume B, Chatellier G, Genes N, Vaur L, Vaisse B, Menard J, Mallion JM: Cardiovascular prognosis of "Masked Hypertension" detected by blood pressure self-measurement in elderly treated hypertensive patients. JAMA. 2004, 291: 1342-1349. 10.1001/jama.291.11.1342.

Guillaume B, Chatellier G, Genes N, Vaur L, Vaisse B, Menard J, Mallion JM: Cardiovascular prognosis of "Masked Hypertension" detected by blood pressure self-measurement in elderly treated hypertensive patients. JAMA. 2004, 291: 1342-1349. 10.1001/jama.291.11.1342.

Mulrow PJ: Hypertension: a worldwide epidemic. Hypertension primer: the essentials of high blood pressure. Edited by: Izzo JL, Black HR, Goodfriend TL. 1999, Baltimore: Williams and Wilkins, 721-273. 2

Wolf-Maier K, Cooper RS, Banegas JR, Gianpaoli S, Hense HW, Joffres M, Kastarinen M, Poulter N, Primatesta P, Rodriguez-Artalejo F, Stegmayr B, Thamm M, Tuomilehto J, Vanuzzo D, Vescio F: Hypertension Prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA. 2003, 289: 2363-2369. 10.1001/jama.289.18.2363.

Kotchen JM, McKean HE, Kotchen TA: Blood pressure trends with aging. Hypertension. 1982, 4 (suppl 3): 11-129.

Franklin SS, Larson MG, Khan SA: Does the relation of blood pressure to coronary heart disease risk change with aging? The Framingham Heart Study. Circulation. 2001, 103: 1245-1249.

Pitt B, Julian D, Pocock S: Clinical Trials in Cardiology. 1997, WB Saunders Company Ltd., London

Mower WR: Evaluating bias and variability in diagnostic test reports. Ann Emerg Med. 1999, 33: 85-91.

Patterson RA, Horowitz SE: Importance of epidemiology and biostatistics in deciding clinical strategies for using diagnostic tests: a simplified approach using examples from coronary artery disease. J Am Coll Cardiol. 1989, 13: 1653-

William BW: Ambulatory blood-pressure monitoring in clinical practice. New Engl J Med. 2003, 348 (24): 2377-2378. 10.1056/NEJMp030057.

Kottke TE, Stroebel R, Hofman R: JNC-7 it's more than high blood pressure. JAMA. 2003, 289 (19): 2573-2575. 10.1001/jama.289.19.2573.

Mulrow PJ: Hypertension: a worldwide epidemic. Hypertension primer: the essentials of high blood pressure. Edited by: Izzo JL, Black HR, Goodfriend TL. 1999, Baltimore: Williams and Wilkins, 721-723. 2

Jekel JF, Elmore JG, Katz DL: Epidemiology Biostatistics and Preventive Medicine. 1996, WB Saunders Company Ltd., Philadelphia

Mayer D: Essential Evidence-Based Medicine. 2004, Cambridge University Press, Cambridge

Campbell NC, Murchie P: Treating hypertension with guidelines in general practice. BMJ. 2004, 329: 523-524. 10.1136/bmj.329.7465.523.

Wong ND, Black HR, Gardin JM: Preventive Cardiology. 2000, McGraw Hill companies, Inc., New York

Alderman M: Blood Pressure Measurement. Individualized Treatment Based on Absolute Risk and the Potential for Benefit. Ann Intern Med. 1993, 119: 329-335.

Prospective Studies Collaboration: Age-specific relevance of usual blood pressure to vascular mortality a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002, 360: 9343-

Alderman MH: Blood Pressure Management: Individualized Treatment Based on Absolute Risk and Potential for Benefit. Ann Intern Med. 1993, 119: 329-335.

Kannel WB: Some lessons in cardiovascular epidemiology from Framingham. Am J Cardiol. 1976, 37: 269-281. 10.1016/0002-9149(76)90323-4.

Kannel WB, Wolf PA, Verter J, McNamara PM: Epidemiologic assessment of the role of blood pressure in stroke. The Framingham Study. JAMA. 1970, 214: 301-310. 10.1001/jama.214.2.301.

Arauz-Pacheco C, Parrott MA, Raskin P: The Treatment of hypertension in adult patients with diabetes. Diabetes Care. 2002, 25 (1): 134-147.

Bakris GL, Weir MR: Achieving goal blood pressure in patients with type 2 diabetes: combination versus fixed-dose combination approaches. J Clin Hypertens. 2003, 5 (3): 202-209.

Deedwania PC: Hypertension and diabetes: new therapeutic options. Arch Intern Med. 2000, 160: 1585-1594. 10.1001/archinte.160.11.1585.

American Diabetes Association: American diabetes Association: clinical practice recommendations 2002. Diabetes Care. 2002, 25 (suppl 1): S1-S147.

Staessen JA, Wang JG, Thijs L: Cardiovascular protection and blood pressure reduction: a meta-analysis. Lancet. 2001, 358: 1305-1315. 10.1016/S0140-6736(01)06411-X.

Gradman AH, Acevedo C: Evolving strategies for the use of combination therapy in hypertension. Curr Hypertens Rep. 2002, 4 (5): 343-349.

Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J: Global burden of hypertension: analysis of worldwide data. Lancet. 2005, 365: 217-223.

Chobanian AV, BAkris GL, Black HR, Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee: Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003, 42: 1206-1252. 10.1161/01.HYP.0000107251.49515.c2.

Stamler J, Stamler R, Neaton JD: Blood pressure, systolic and diastolic, and cardiovascular risks. US population data. Arch Intern Med. 1993, 153: 598-625. 10.1001/archinte.153.5.598.

World Health Organization-International Society of Hypertension Guidelines for Management of Hypertension. Guidelines Subcommittee. J Hypertens. 1999, 17: 151-183.

Hotline Editorial: Rates of progression to hypertension among non-hypertensive subjects: implications for blood pressure screening. Eur Heart J. 2002, 23: 6067-1070.

Vasan RS, Larsan MG, Leip EP, Kannel WB, Levy D: Assessment of frequency of progression to hypertension in non- hypertensive participants in the Framingham Heart Study: a cohort study. Lancet. 2001, 358: 1682-1686. 10.1016/S0140-6736(01)06710-1.

Pickering TG: Utility of 24-hour ambulatory blood pressure monitoring in clinical practice. Can J Cardiol. 1995, 11: 43H-48H.

Staessen J, Fagard R, Lijnen P, Thijs L, van Hoof R, Amery A: Ambulatory blood pressure monitoring in clinical trials. J Hypertens Suppl. 1991, 9 (suppl 1): S13-S19.

Staessen J, Fagard R, Lijnen P, Thijs L, van Hoof R, Amery A: Reference values for ambulatory blood pressure: a meta-analysis. J Hypertens. 1990, 8 (suppl 6): S57-S64.

O'Brien E, Murphy J, Tyndall A: Twenty-four-hour ambulatory blood pressure in men and women aged 17 to 80 years: the Allied Irish Bank Study. J Hypertens. 1990, 9: 355-360.

ISH Scientific Committee: Consensus document on non-invasive ambulatory blood pressure monitoring. J Hypertens. 1990, 8 (suppl 6): S136-S140.

Sega R, Trocino G, Lanzarotti A, Carugo S, Cesana G, Schiavina R, Valagussa F, Bombelli M, Giannattasio C, Zanchetti A, Mancia G: Alterations of cardiac structure in patients with isolated office, ambulatory, or home hypertension: data from the general population (Pressione Arteriose Monitorate E Loro Associazioni [PAMELA] Study). Circulation. 2001, 104: 1385-1392.

Selenta C, Hogan BE, Linden W: How Often Do Office Blood Pressure Measurements Fail to Identify True Hypertension? An Exploration of White-Coat Normotension. Arch Fam Med. 2000, 9: 533-540. 10.1001/archfami.9.6.533.

Prisant LM: Ambulatory blood pressure monitoring in the diagnosis of hypertension. Cardiol Clin. 1995, 13: 479-490.

O'Brien E, Mee F, Atkins N, O'Malley K: Accuracy of the Spacelabs 90207 determined by the British Hypertension Society Protocol. J Hypertens. 1991, 5: 573-574.

Liu JE, Roman MJ, Pini R, Schwartz JE, Pickering TG, Devereux RB: Elevated ambulatory with normal clinic blood pressure ("white coat normotension") is associated with cardiac and arterial target organ damage. Ann Intern Med. 1999, 131: 564-572.

Pickering TG, James GD, Boddie C, Harsfield GA, Blank S, Laragh JH: How common is white-coat hypertension?. JAMA. 1988, 259: 225-228. 10.1001/jama.259.2.225.

Staessen JA, Thijs L, Fagard R, for the Systolic Hypertension in Europe Trial Investigators, et al: Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. JAMA. 1999, 282: 539-546. 10.1001/jama.282.6.539.

White WB, Schulman P, McCabe EJ, Dey HM: Average daily blood pressure, not office pressure, determines cardiac function in patients with hypertension. JAMA. 1989, 261: 873-877. 10.1001/jama.261.6.873.

Mancia G, Zanchetti A: White-coat hypertension: misnomers, misconceptions and misunderstandings. What should we do next?. J Hypertens. 1996, 14: 1049-1052.

Verdecchia P, Clement D, Fagard R, Palatini P, Parati G: Target organ damage, morbidity and mortality. Blood Pressure Monitoring. 1999, 4: 303-317.

Pickering TG, Coats A, Mallion JM, Mancia G, Verdecchia P, Task Force V: White-coat hypertension. Blood Pressure Monitoring. 1999, 4: 333-341.

William BW: Ambulatory blood-pressure monitoring in clinical practice. New Engl J Med. 2003, 348 (24): 2377-2378. 10.1056/NEJMp030057.

Little P, Barnet J, Barnsley L, Marjoram J, Fitzgerald-Baron A, Mant D: Comparison of agreement between different measures of blood pressure in primary care and daytime ambulatory blood pressure. BMJ. 2002, 325: 254-259. 10.1136/bmj.325.7358.254.

Bellomo G, Narducci PL, Rondoni F, Pastorelli G, Stagnoni G: Prognostic value of 24-hour blood pressure in pregnancy. JAMA. 1999, 282: 1447-1452. 10.1001/jama.282.15.1447.

Mancia G, Bertineri G, Grassi G: Effects of blood pressure measured by the doctor on patient's blood pressure and heart rate. Lancet. 1983, 2: 695-698. 10.1016/S0140-6736(83)92244-4.

Myers MG, Haynes B, Rabbkin SW: Canadian Hypertension Society Guidelines for Ambulatory Blood Pressure Monitoring. Am J Hypertens. 1999, 12: 1149-1157. 10.1016/S0895-7061(99)00199-5.

Myers MG, Reeves RA: White-coat phenomenon in patients receiving antihypertensive therapy. Am J Hypertens. 1991, 4: 844-849.

Myers MG, Reeves RA: White-coat effect in treated hypertensive patients: sex difference. J Hum Hypertens. 1995, 9: 729-733.

O'Brien E: Ambulatory blood pressure monitoring in the management of hypertension. Heart. 2003, 89: 571-576. 10.1136/heart.89.5.571.

Brawn LA, Castleden CM: Adverse drug reactions: an overview of special considerations in the management of the elderly patient. Drug Safety. 1990, 5: 421-435.

Rochon PA, Anderson GM, Tu JV: Age- and gender-related use of low-dose drug therapy: the need to manufacture low-dose therapy and evaluate the minimum effective dose. J Am Geriatr Soc. 1999, 47: 954-959.

Tomlinson B: Optimal dosage of ACE inhibitors in older patients. Drugs Aging. 1996, 9: 262-273.

Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure: The Sixth Report of the Joint National Committee on detection, evaluation, and treatment of high blood pressure. Arch Intern Med. 1997, 157: 2413-1446. 10.1001/archinte.157.21.2413.

Guidelines Subcommittee: 1999 WHI/ISH Guidelines for the management of hypertension. J Hypertens. 1999, 17: 151-183.

Ramsay LE, Williams B, Johnston GD, MacGregor GA, Poston L, Potter JF, Poulter NR, Russel G: British Hypertension Society Guidelines for hypertension management 1999: summary. Br Med J. 1999, 519: 17630-635.

Centers for Medicare & Medicaid Services: Medicare coverage policy – decisions. ABPM monitoring (#CAG-00067N). 2001, [http://www.hcfa.gov/coverage/8b3-ff.htm]

Krishan G: Isolated Office Hypertension: Ambulatory BP Monitoring Is the Only Answer. Arch Intern Med. 2002, 162 (13): 1526-10.1001/archinte.162.13.1526.

Staessen JA, O'Brien E, Thijs L, Fagard RH: Modern approaches to blood pressure measurement. Occup Environ Med. 2000, 57: 510-520. 10.1136/oem.57.8.510.

Ferrucci L, Furberg CD, Penninx BW: Treatment of isolated systolic hypertension is most effective in older patients with high-risk profile. Circulation. 2001, 104: 1923-1926.

Pocock SJ, McCormack V, Gueyffier F, Boutitie F, Fagard RH, Boissel JP: A score for predicting risk of death from cardiovascular disease in adults with raised blood pressure, based on individual patient data from randomized controlled trials. BMJ. 2001, 323: 75-81. 10.1136/bmj.323.7304.75.

O'Rourke J, Richardson SW: Evidence based management of hypertension: what to do when blood pressure is difficult to control. BMJ. 2001, 322: 1229-1232. 10.1136/bmj.322.7296.1229.

Pickering TG: Ambulatory blood pressure monitoring. Curr Hypertens Rep. 2000, 2: 558-564.

Prasad N, Isles C: Ambulatory blood pressure monitoring: a guide for general practitioners. BMJ. 1996, 313: 1535-1541.

O'Brien E, Coats A, Owens P, Petries J, Padfield P, Littler W: Use and interpretation of ambulatory blood pressure monitoring: recommendations of the British Hypertension Society. BMJ. 2000, 320: 1128-1134. 10.1136/bmj.320.7242.1128.

Ramsey L, Williams B, Johnson G, MacGregor GA, Poston L, Potter J: Guidelines for management of hypertension: report of the third working party of the British Hypertension Society. J Hum Hypertens. 1999, 13: 569-592. 10.1038/sj.jhh.1000917.

Devereux RB, Pickering TG: Relationship between the level, pattern and variability of ambulatory blood pressure and target organ damage in hypertension. J Hypertens Suppl. 1991, 9 (suppl 8): S34-S38.

Giaconi S, Levanti C, Fommei E: Microalbuminuria and casual and ambulatory blood pressure monitoring in normotensives and in patients with borderline and mild essential hypertension. Am J Hypertens. 1989, 2: 259-261.

Shimada K, Kawanato A, Matsubayishi K, Ozawa T: Silent cerebrovascular disease in the elderly: correlation with ambulatory pressure. Hypertension. 1990, 16: 692-699.

Mancia G, Zanchetti A, Agebiti-Rosei E: Ambulatory blood pressure is superior to clinic blood pressure in predicting treatment-induced regression of left-ventricular hypertrophy. Circulation. 1997, 95: 1464-1470.

Ohkubo T, Imai Y, Tsuji I: Prediction of mortality by ambulatory blood pressure monitoring versus screening blood pressure measurements: a pilot study in Ohasama. J Hypertens. 1997, 15: 357-364. 10.1097/00004872-199715040-00006.

Staessen JA, Thijs L, Fagard R: Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. JAMA. 1999, 282: 539-546. 10.1001/jama.282.6.539.

Perloff D, Sokolow M, Cowan R: The prognostic value of ambulatory blood pressures. JAMA. 1983, 249: 2792-2798. 10.1001/jama.249.20.2792.

Redon J, Campos C, Narciso ML, Rodicio JL, Pascual JM, Ruilope LM: Prognostic value of ambulatory blood pressure monitoring in refractory hypertension: a prospective study. Hypertension. 1998, 31: 712-718.

Verdecchia P, Porcellati C, Schillaci G: Ambulatory blood pressure, an independent predictor of prognosis in essential hypertension. Hypertension. 1994, 24: 793-801.

Ernst EE, Bergus GR: Favorable patient acceptance of ambulatory blood pressure monitoring in a primary care setting in the United States: a cross-sectional survey. BMC Family Practice. 2003, 4: 15-10.1186/1471-2296-4-15.

Thông tin
Thông tin xuất bản

Current Controlled Trials in Cardiovascular Medicine

Thông tin tác giả